STATs directly target genes that regulate cell cycle, such as cyclin D1, p21, c-myc, and apoptosis, such as Bcl-xL and Mcl-1 (myeloid cell leukemia sequence 1), and thus may also affect cellular response to anti-cancer drugs [95]. The gene discussed is BCL2L1; the disease is cancer.